Parameters | TTS | Controls | p-value | |
---|---|---|---|---|
Population, n | 50 | 30 |  −  | |
Age, years | 69 ± 13 | 63 ± 11 | 0.354 | |
Sex, females, n (%) | 50 (100) | 30 (100) | 1.000 | |
Body mass index, kg/m2 | 25.7 ± 5.6 | 26.2 ± 4.7 | 0.547 | |
Hypertension, n (%) | 16 (32) | 10 (33) | 0.273 | |
Hyperlipidemia, n (%) | 9 (18) | 6 (20) | 0.588 | |
Diabetes, n (%) | 2 (4) | 3 (10) | 0.612 | |
Smoke, n (%) | 8 (16) | 7 (23) | 0.595 | |
Ex-smoker, n (%) | 2 (4) | 4 (13) | 0.148 | |
Onset-to-CMR, days | 11.2 ± 6.5 |  −  |  −  | |
Phenotype, n (%) | Apical | 36 (72) |  −  |  −  |
Mid | 8 (16) |  −  |  −  | |
Basal | 2 (4) |  −  |  −  | |
Focal | 4 (8) |  −  |  −  | |
lvEF range, n (%) |  < 40% | 6 (12) |  −  |  −  |
40–50% | 10 (20) |  −  |  −  | |
51–60% | 21 (42) | 8 (26) | 0.127 | |
 > 60% | 13 (26) | 23 (74) | 0.001 | |
lvESV/BSA, mL/m2 | 35.6 ± 15 | 23.9 ± 9.6 |  < 0.001 | |
lvEDV/BSA, mL/m2 | 74.6 ± 16.8 | 65.7 ± 10.6 | 0.011 | |
lvEF, % | 52.2 ± 11 | 63.1 ± 5.9 |  < 0.001 | |
rvESV/BSA, mL/m2 | 31.8 ± 10.3 | 31 ± 11 | 0.758 | |
rvEDV/BSA, mL/m2 | 70.8 ± 15.2 | 73 ± 14.7 | 0.535 | |
rvEF, % | 55.1 ± 8.7 | 58 ± 8.1 | 0.141 | |
laEDV, mL//m2 | 63.4 ± 22.3 | 59.7 ± 18.3 | 0.058 | |
laS_r, % | 19.3 ± 2.9 | 24 ± 2.8 |  < 0.001 | |
laS_cd, % | 8.7 ± 3.4 | 12.5 ± 2.6 |  < 0.001 | |
laS_bp, % | 10.8 ± 2.6 | 9.7 ± 1.9 | 0.041 | |
laSR_r, L/s | 0.8 ± 0.2 | 1.2 ± 0.4 |  < 0.001 | |
laSR_cd°, L/s (median [IQR]) | -0.7, (-0.7, -0.3) | -1.1, (-2.0, -0.6) |  < 0.001 | |
laSR_bp, L/s | -1.1 ± 0.3 | -1.3 ± 0.5 | 0.032 | |
laGRS, % | 36.3 ± 11.9 | 52.8 ± 9.8 |  < 0.001 | |
lvGRS, % | 25.2 ± 7.7 | 33.6 ± 8.2 | 0.005 | |
lvGCS, % | -15.5 ± 3.5 | -21.8 ± 2.9 |  < 0.001 | |
lvGLS, % | -14 ± 4.1 | -19.7 ± 2.6 |  < 0.001 | |
lvGRSR, L/s | 1.2 ± 0.3 | 1.6 ± 0.3 | 0.002 | |
lvGCSR°, L/s | -0.8, (-1.3, -0.9) | -1.0, (-1.2, -0.8) |  < 0.001 | |
lvGLSR, L/s | -0.7 ± 0.2 | -1.2 ± 0.9 | 0.001 | |
lvEdema, n (%) | 50 (100) | 0 (0) |  < 0.001 | |
lvLGE, n (%) | 3 (6) | 0 (0) | 0.892 |